Association of initial imaging modality and futile recanalization after thrombectomy. by Meinel, Thomas Raphael et al.
Neurology Publish Ahead of Print
DOI: 10.1212/WNL.0000000000010614
1 
 
 
 
 
 
Association of initial imaging modality and futile recanalization after thrombectomy  
Running title: MRI vs CT for thrombectomy selection 
Authors: Thomas Raphael Meinel, MDa*, Johannes Kaesmacher, MDb*, Pascal John 
Mosimann, MDc, David Seiffge, MDa, Simon Jung, Profa, Pasquale Mordasini, MDc, Marcel 
Arnold, Profa, Martina Goeldlin, MDa, Steven D. Hajdu, MDd, Marta Olivé-Gadea, MDe, 
Christian Maegerlein, MDf, Vincent Costalat, Profg, Laurent Pierot, Profh, Joanna D 
Schaafsma, MDi Urs Fischer, Profa* & Jan Gralla, Profb* 
 
The Article Processing Charge was funded by the Department of Neurology, Inselspital, University of 
Bern. 
 
This is an open access article distributed under the terms of the Creative Commons Attribution-
NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and 
sharing the work provided it is properly cited. The work cannot be changed in any way or used 
commercially without permission from the journal. 
 
Neurology® Published Ahead of Print articles have been peer reviewed and accepted for 
publication. This manuscript will be published in its final form after copyediting, page 
composition, and review of proofs. Errors that could affect the content may be corrected 
during these processes. 
 
AC
CE
PT
ED
Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.
 Published Ahead of Print on August 26, 2020 as 10.1212/WNL.0000000000010614
s
o
u
r
c
e
:
 
h
t
t
p
s
:
/
/
d
o
i
.
o
r
g
/
1
0
.
7
8
9
2
/
b
o
r
i
s
.
1
4
6
2
0
5
 
|
 
d
o
w
n
l
o
a
d
e
d
:
 
2
7
.
1
2
.
2
0
2
0
2 
 
a Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Switzerland 
b Institute of Diagnostic and Interventional Neuroradiology, Institute of Diagnostic, Interventional and 
Pediatric Radiology and Department of Neurology, University Hospital Bern, Inselspital, University of 
Bern, Bern, Switzerland. 
c Department of Neuroradiology, Inselspital, Bern University Hospital, University of Bern, 
Switzerland 
d Department of Radiology, Lausanne University Hospital, Lausanne, Switzerland 
e Department of Neurology, Department of Neurology, Vall d'Hebron University Hospital, Barcelona, 
Spain. 
f Department of Diagnostic and Interventional Neuroradiology, Klinikum rechts der Isar, Technical 
University Munich, Munich, Germany 
g Department of Neuroradiology, CHU Montpellier, Montpellier, France 
h Department of Neuroradiology, CHU Reims, Reims, France 
i Department of Neurology Medicine, Division of Neurology, Toronto Western Hospital, Toronto, 
ON, Canada 
 
* equal contributions 
Corresponding author: Urs Fischer (urs.fischer@insel.ch)   
Association of initial imaging modality and futile recanalization after thrombectomy 
Running title: MRI vs CT for thrombectomy selection 
 
Characters title: 89 
Characters running head: 36 
Figures: 3 
Tables: 4 
AC
CE
PT
ED
Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.
3 
 
Total: 6    
Word count abstract: 259 
Word count Keywords: 5 
Word count main text: 3087  
Word count all: 6378 
References: 27 
Online Supplement: No, Dryad Data Depository 
 
Study Funding: The study was supported by Medtronic (Dublin, Ireland). Medtronic did not 
take part in the conception, design or manuscript draft of this study. 
Disclosure:  
T. Meinel reports do disclosures relevant to the manuscript. 
J. Kaesmacher reports grants from Swiss Stroke Society and grants from SAMW/Bangerter 
Foundation during the conduct of the study.  
P. Mosimann reports no disclosures relevant to the manuscript. 
D. Seiffge reports other from Bayer Foundation outside the submitted work. 
S. Jung and P. Mordasini report no disclosures relevant to the manuscript.  
M. Arnold reports grants from Swiss Heart Foundation.  
M. Arnold reports personal fees from Covidien and personal fees from Medtronic during the 
conduct of the study; personal fees from Bayer, personal fees from BMS, personal fees from 
AC
CE
PT
ED
Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.
4 
 
Amgen, personal fees from Daiichy Sankio, and personal fees from Nestle Heatlth Sciences 
outside the submitted work. 
M. Goeldlin reports grants from Bangerter-Rhyner-Foundation during the conduct of the 
study. S. Hajdu, M. Olivé-Gadea  
C. Maegerlein reports no disclosures relevant to the manuscript. 
V. Costalat reports grants from Medtronic, grants from Stryker, grants from Microvention, 
grants from Cerenovus Penumbra, and grants from Balt outside the submitted work. 
L. Pierot reports personal fees from Balt, personal fees from Microvention, personal fees from 
Phenox, and personal fees from Vesalio outside the submitted work. 
J. Schaafsma reports no disclosures relevant to the manuscript.  
U. Fischer reports grants from Medtronic during the conduct of the study; grants and other 
from Medtronic, other from Medtronic, other from Stryker, and other from CSL Behring 
outside the submitted work.  
J. Gralla reports grants from Medtronic and other from Penumbra outside the submitted work.  
 
AC
CE
PT
ED
Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.
5 
 
 
Abstract 
Objective: To test the hypothesis that selection by initial imaging modality (MRI vs CT) is 
associated with rate of futile recanalizations (FR) after mechanical thrombectomy (MT), we 
assessed this association in a multicenter, retrospective observational registry (BEYOND-
SWIFT, NCT03496064).  
Methods: In 2011 patients (49.7% female, median age 73 [61-81]) included between 2009 
and 2017, we performed univariate and multivariate analyses regarding the occurrence of FR. 
FR were defined as 90 day modified Rankin Scale (mRS) 4-6 despite successful 
recanalization in patients selected by MRI (N=690) and CT (N=1321) with a sensitivity 
analysis considering only patients with mRS 5-6 as futile.   
Results: MRI as compared to CT resulted in similar rates of subsequent MT (aOR 1.048, 95% 
CI 0.677 – 1.624). Rates of FR were as follows: 571/1489 (38%) FR mRS 4-6 including 
393/1489 (26%) FR mRS 5-6. CT based selection was associated with increased rates of futile 
recanalizations compared to MRI (44%[41-47%] vs. 29%[25-32%], p < 0.001; aOR 1.77 
(95%-CI: 1.25-2.51)). These findings were robust in sensitivity analysis. MRI-selected 
patients had a delay of approximately 30 minutes in workflow metrics in real-world university 
comprehensive stroke centers. However, functional outcome and mortality were more 
favorable in patients selected by MRI compared to patients selected with CT. 
Conclusions: CT-selection for MT was associated with an increased risk of futile 
recanalizations as compared to MR-selection. Efforts are still needed to shorten workflow 
delays in MRI patients. Further research is needed to clarify the role of the initial imaging 
modality on FR occurrence and to develop a reliable FR prediction algorithm.  
Key words: Acute ischemic stroke – MRI – CT – Futile Recanalization – Endovascular  
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Introduction: 
Despite the overwhelming efficacy of mechanical thrombectomy (MT) for endovascular 
treatment of acute ischemic stroke (AIS), up to 25-50% of patients have a poor long-term 
outcome (modified Rankin Scale or mRS 4-6) despite successful recanalization – a 
phenomenon termed futile recanalization (FR) (1–3).  
 
From a patient’s perspective, being bedridden, incontinent and requiring constant nursing 
(mRS 5) or dead (mRS 6) can indeed be assumed to represent a futile outcome. Some, 
however, might consider moderately severe disability requiring assistance to attend to bodily 
needs or to walk (mRS 4) an acceptable, non-futile outcome. From a societal and health 
economics point of view, given the logistic and economic impact of endovascular treatment, 
there is a need to reduce FR (2,4). Known predictors of FR include age, National Institute of 
Health Stroke Scale (NIHSS) (2,5), procedure time (6), and leukoaraiois (7).  However, the 
role of the initial imaging modality for patient selection on the rate of FR remains unclear (8). 
We hypothesized that imaging modality influences decisions regarding which patients to treat 
by MT hence resulting in a different rate of FR.  
 
Therefore, the main objectives of this study were to: 1) determine the rate of FR in patients 
undergoing MT selected by MRI versus CT in a large multi-center registry; 2) identify 
relevant secondary outcomes, such as workflow metrics, sICH, mortality, and functional 
outcome according to initial imaging modality. 
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Methods 
Briefly, this multi-center, retrospective, international, non-randomized observational registry 
was designed to investigate the safety and efficacy of a second-generation market-released 
neurothrombectomy device in borderline indications for treatment of AIS patients. In the 2007 
period (Center Munich), this included treatment with a Solitaire AB used as retrievable Stent. 
Medtronic provided financial funding of the registry.  
Inclusion criteria of the registry were treatment with a Medtronic market-released 
thrombectomy device for an intracranial large vessel occlusion with attributable neurological 
symptoms. Current participation in another clinical trial was the only exclusion criterion. For 
this analysis, we included all patients from the registry with available information on initial 
imaging modality. Between 26 – 90% of all patients treated by MT at each center during the 
study timeframe were included in this registry. Choice of imaging modality was center-
specific and not specified. Four centers used mainly CT, two centers mainly MRI and the 
biggest center used CT and MRI in equal parts (Figure e-1: https://doi.org/ 
10.5061/dryad.f4qrfj6t1). Reasons why patients underwent CT or MRI were not available as a 
data item in the registry, but were provided by the local principal investigator for the study 
timeframe (from Dryad Table 1: https://doi.org/ 10.5061/dryad.f4qrfj6t1). Local principal 
investigators also provided their approach for patient selection in the study timeframe (from 
Dryad Table 1: https://doi.org/ 10.5061/dryad.f4qrfj6t1) and all centers that had access to both 
modalities, based their decisions on a tissue-based approach with somewhat similar 
indications to perform MT. Cerebral microbleeds were no absolute contraindication for 
intravenous thrombolysis or endovascular treatment in the centers that used MRI as initial 
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imaging modality. A clear-cut intracranial hemorrhage excluded both IVT and EVT in all 
centers.  
Indications for MRI as opposed to CT included both favorable prognostic features (low 
NIHSS, no contraindications such as vomiting or pacemakers) as well as unfavorable  
prognostic features (posterior circulation large vessel occlusion including basilar artery 
occlusion, intubated patients, and unknown onset time). Choice of EVT after imaging was a 
tissue-based approach in all participating centers putting slightly different emphasis on 
NIHSS, time elapsed, infarct core/ASPECTS, collaterals and overall prognosis (from Dryad 
Table 1: https://doi.org/ 10.5061/dryad.f4qrfj6t1).   
Variables and Image analysis 
Operators or independent research fellows at each center determined the site of large vessel 
occlusion and postinterventional recanalization according to the modified thrombolysis in 
cerebral infarction (mTICI) scale. Successful recanalization was defined as mTICI ≥ 2b,
representing at least 50% antegrade angiographic reperfusion downstream of the initially 
occluded target territory (10). Tandem occlusion was defined as an intracranial large vessel 
occlusion coupled with an ipsilateral extracranial occlusion or a stenosis of 90% or more. For 
the subgroup analysis of ASPECTS, 1 point was added in MRI patients to correct for the 
differences in DWI-ASPECTS as compared to CT-ASPECTS (11).  
Outcomes  
The primary endpoint of this analysis was FR, which was defined as modified Rankin Scale 
(mRS) 4-6 at 90 days despite successful endovascular recanalization (mTICI ≥ 2b) (12). 
Secondary outcomes included a sensitivity analysis defining FR as mRS 5-6 at 90 days, all-
cause mortality at 90 days, symptomatic intracranial hemorrhage (sICH), which was assessed 
at each center applying the European Co-operative Acute Stroke Study-II (ECASS II) criteria 
(13) and good functional outcome (mRS 0-2) at 90 days. The mRS score at 90 days was 
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obtained either in routinely scheduled clinical visits or by using standardized telephone 
interviews.  
Statistical analysis 
As the patients not undergoing MT were not collected in BEYOND-SWIFT, we sought to 
address the issue which parameters were associated with undergoing MT according to each 
imaging modality in the local database (2015 – 2018) from the biggest participating center 
(Bern). For this purpose, patients that had a vessel occlusion in the suspected ischemic 
territory presenting between 0 – 48 hours after symptom onset were compared with 
univariable analysis as outlined above. A backward stepwise multiple logistic regression 
analysis was performed to identify factors associated with performing subsequent MT. Then, 
age, sex and the imaging modality was added to the model to analyze, whether the imaging 
modality itself was associated with MT decisions.  
In the BEYOND-SWIFT dataset, we compared the imaging groups (MRI versus CT) using 
Chi squared and and Fisher’s exact tests for categorical variables, Whitney-Mann-U-Test for 
non-normally continuous or ordinally scaled variables, and Welsch’s t-test for independent 
normally distributed data.  
For the primary analysis of a pre-interventional model, the association of imaging type (MRI 
versus CT) with all outcome parameters was assessed using multivariable logistic regression 
adjusting for the following pre-specified confounders: age (continuous), sex (categorical), 
NIHSS on admission (ordinal, adjusted odds ratio [aOR] per point increase), known symptom 
onset (categorical), pre-stroke independence (mRS 0-2; categorical), hypertension 
(categorical), diabetes (categorical), smoking (categorical), previous stroke (categorical), 
center (categorical, contrast type: comparator; indicator: largest center), anterior vs posterior 
circulation (categorical), time from symptom onset to groin puncture (continuous), and 
intravenous thrombolysis (categorical). For the prognostic post-interventional model, the 
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following additional confounders were included: TICI 3 versus TICI 2b (categorical), use of 
balloon guiding catheter (categorical), intracranial stenting (categorical), general anesthesia 
(categorical), time from groin puncture to recanalization (continuous), and number of passes 
(ordinal, adjusted odds ratio [aOR] per pass). The rationale for both models was the 
combination of known predictors of FR following EVT (2,5) and baseline and interventional 
differences of patients with and without FR factoring in the (multi)collinearity between 
variables (from Dryad Table 2: https://doi.org/ 10.5061/dryad.f4qrfj6t1). In a post-hoc 
analysis, an ordinal shift analysis was applied using the same covariates and factors as stated 
above.  
We excluded patients with missing data items from the multivariate analysis. For the 
sensitivity analysis, the same model was used to assess the association of imaging modality 
with FR defined as mRS 5-6 at 90 days, despite successful recanalization. We used a level of 
significance of 0.05. All analysis were performed with SPSS Version 25. 
Standard Protocol Approvals, Registrations, and Patient Consents: Details on the registry 
(BEYOND-SWIFT) are registered at NCT03496064 and further details were previously 
published (9). Patient consent was obtained according to Good Clinical Practice and/or 
institutional review board and/or local or institutional policies. 
Data Availability: anonymized data will be shared by request from any qualified investigator 
after clearance by the ethics committee.  
Results: 
Baseline 
See Figure 1 for the registry flowchart. The rates of FR were as follows: 38% (571/1489) FR 
mRS 4-6 including 26% (393/1489) FR mRS 5-6 and 62% (918/1489) non-FR with mRS 0-3 
at three months. 1213/1489 (81.5%) patients were included in the primary multivariable 
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analysis. Missing information on symptom onset to groin puncture (248) was the main 
missing data item.  
[insert figure 1] 
Baseline characteristics and univariate comparisons of patients according to imaging modality 
are presented in table 1.  
[insert table 1] 
Characteristics and univariate comparisons of patients with FR and without FR are presented 
in table 2. Patients with FR were older, had more severe stroke, were more often dependent 
before stroke onset, had higher glucose levels, less often witnessed symptom onset, a different 
cardiovascular risk profile, and more often a posterior circulation large vessel occlusion.  
[insert table 2] 
In the single-center analysis of the biggest participating center, patients with MRI as the initial 
imaging modality had a lower crude proportion of subsequent MT as compared to CT patients 
(61.8% vs. 80.1%, P<0.001). However, after adjustments for baseline differences, MRI as 
compared to CT was not associated with a lower rate of subsequent MT (aOR 1.048, 95% CI 
0.677 – 1.624). Of the baseline factors, NIHSS (aOR 1.198 95% CI 1.156 - 1.241 per 1 point 
increase), posterior circulation large vessel occlusion (aOR 0.352 95% CI 0.228 - 0.542), 
preceding oral anticoagulation (aOR 2.610 95% CI 1.062 - 6.418) and treatment with 
intravenous thrombolysis (aOR 0.296 95% CI 0.203 - 0.432) were significantly associated 
with subsequent MT. 
Univariate Analysis 
Univariate outcomes are presented in table 3. Patients selected by MRI as compared to CT 
had lower rates of futile recanalization (28.6% [25-32%] vs 43.8% [41-47%], P<0.001). This 
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finding remained consistent when only considering successfully recanalized patients with 
mRS 5-6 as FR (18.6% [15-22%] vs 30.7% [28-34%], P<0.001).   
[insert table 3] 
Multivariate analysis 
According to the multivariable binary logistic regression analysis adjusting for prespecified 
confounders outlined in the methods section, CT was associated with increased odds for FR 
(aOR 1.770, 95%-CI 1.251 – 2.506, Figure 2) as compared to MRI selection. This finding was 
consistent when using an ordinal shift analysis (aOR for the association of MRI with mRS 
0.689, 95% CI 0.556 – 0.854). In the sensitivity analysis considering patients with mRS 5-6 as 
futile, the point estimate was very similar (aOR 1.758, 95%-CI 1.197– 2.583).  
Of the prespecified confounders, age (per 1 year aOR 1.043, 95%-CI 1.031 – 1.055), NIHSS 
on admission (per 1 point aOR 1.087, 95%-CI 1.066 – 1.109), pre-stroke-independence (aOR 
0.239, 95%-CI 0.138 – 0.414), diabetes (aOR 1.782, 95%-CI 1.254 – 1.532) and arterial 
hypertension (aOR 0.727, 95%-CI 0.530 – 0.997) were associated with FR.   
[insert figure 2] 
 
Postinterventional model 
Also in the postinterventional multivariate model adjusting for additional interventional 
confounders, CT significantly increased the odds of having FR as compared to MRI selection 
(aOR 1.858, 95%-CI 1.285 – 2.687). Also in this model, the results were consistent when 
using an ordinal shift analysis (aOR for the association of MRI with mRS 0.639, 95% CI 
0.494 – 0.827). Of the periinterventional confounders, complete recanalization TICI 3 (aOR 
0.607, 95%-CI 0.432 – 0.853), intracranial stenting (aOR 2.620 ,95%-CI 1.071 - 6.406) and 
maneuver count (per 1 pass aOR 1.253, 95%-CI 1.077 – 1.457) were associated with FR.  
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Subgroup analyses 
Our main finding of an increased risk of futile recanalization in patients selected by CT were 
consistent throughout subgroups according to centers, anterior as compared to posterior 
circulation (p for interaction P=0.862), occlusion site and low and high ASPECTS score 
(Figure 3 and from Dryad Table 3: https://doi.org/ 10.5061/dryad.f4qrfj6t1). When restricting 
the analysis to patients with known time of symptom onset, the increased risk of futile 
recanalization in patients selected by CT was robust also in patients presenting 0-6 hours after 
known symptom onset (aOR 1.757, 95% CI 1.168 – 2.644) and the point estimate suggested 
an ever more pronounced association for patients presenting beyond 6 hours (aOR 24.6, 95% 
CI 0.557 – 1087), without reaching significance in this small subgroup. In patients with 
known symptom onset, there was no interaction of imaging type and presentation within 6 
hours (P=0.782).  
Secondary outcomes: 
There was no difference in time from symptom onset to hospital admission between the 
imaging modalities (Table 4). However, there was a time delay of 24 minutes from admission 
to groin puncture and 37 minutes from onset of symptoms to IVT needle in patients 
undergoing MRI. Rates of sICH were higher in patients selected with CT (7.0% vs 4.4%, P = 
0.018), although this was non-significant after adjustments (aOR 1.087, 95%-CI 0.552 – 
2.141). Rates of good functional outcome (mRS 0-2) were lower on univariate (39.5% vs 
50.1%, P<0.001) and multivariable analysis (aOR 0.539, 95%-CI 0.395 – 0.735) in patients 
selected with CT as compared to MRI. Fittingly, mortality at three months was higher in 
patients selected with CT on univariate (28.1% vs 20.5%, P<0.001) and multivariable analysis 
(aOR 1.613, 95%-CI 1.153 – 2.257). Additional analysis regarding influence of imaging 
modality on subsequent MT and pattern of vessel occlusions according to imaging modality 
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and occurrence of FR are available from Dryad (Tables 4-7: https://doi.org/ 
10.5061/dryad.f4qrfj6t1).  
[insert table 4] 
[insert figure 3] 
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Discussion: 
The main findings concerning the initial imaging selection modality for endovascular 
treatment in patients with acute ischemic stroke based on this multi-center registry analysis 
are:  
 (1) As compared to patients selected with CT, use of MRI was associated with a decreased 
risk of futile recanalization. (2) Patients selected by MRI have an unadjusted delay of roughly 
half an hour in workflow metrics in real-world university comprehensive stroke centers. (3) 
Nonetheless, as compared to patients selected with CT, functional outcome and mortality 
were more favorable in patients selected by MRI even after multivariable adjustments.  
Despite the effectiveness of endovascular stroke treatment, the rate of FR remains very high 
(2). Hence, there is a need to reduce futile interventions (4) to protect patients’ autonomy and 
limit healthcare costs. Whether selection by MRI as opposed to CT actually results in a higher 
(8,14) or a lower indication rate for EVT (15) depends on the detailed imaging protocol, time 
from symptom onset to imaging and decision algorithm. In our analysis, there was no 
influence of the initial imaging modality on MT rates.  
 
In our analysis, MRI as the initial imaging modality compared to triage with CT was 
associated with a reduced rate of FR in high-volume comprehensive stroke centers. Several 
factors may explain this finding. Firstly, MRI often provides more clear-cut information 
compared to CT ASPECTS and may facilitate treatment decisions in complex clinical 
scenarios. Diffusion weighted imaging as compared to CT-perfusion, in particular, may 
provide a different estimate of the ischemic core translating into improved individual patient 
selection in real-world clinical conditions (8,16,17). Moreover, MRI-selected patients seem to 
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have a lower rate of sICH, as also shown in a recent Korean study (18) (see below) which 
may explain the lower frequency of FR, given the association between sICH and poor 
outcome.  
 
Since the breakthrough of endovascular stroke therapy, indications to perform MT are 
constantly expanding which may increase the rate of FR. Given the benefit of MT in almost 
all subgroup analyses, the role of imaging – at least in the early phase – is gradually shifting 
from selecting patients to deselecting patients. According to our results, MRI might be the 
more useful tool to identify patients who will most likely not benefit from EVT even in case 
of successful recanalization. Combining clinical factors like advanced age, pre-stroke 
dependency, high stroke severity and expected time to recanalization with MR-specific 
factors, such as large ischemic core volume might lead to a predictive FR score in the future, 
which remains beyond the scope of the present study. We think the main concern in this 
context is, that the use of MRI may lead to supraselection of eligible AIS patients benefitting 
from MT. Machine learning and artificial intelligence represent promising tools to precisely 
determine whether MT will be beneficial or futile on an individual basis for AIS patients 
(19,20), but until then the positive predictive value of any simple “FR algorithm” should be as 
high as possible to avoid withholding an evidence-based treatment from otherwise suitable 
patients for endovascular recanalization therapies.  
In randomized controlled trials, no significant in-center delay was noted for patients 
undergoing MRI as compared to CT (21,22), although perfusion imaging was performed only 
in a minority of subjects (22). Despite longer imaging duration, no impact on onset-to-needle 
and onset-to-groin time was seen in those trials - possibly because of facilitated treatment 
decisions by DWI images with clear-cut signal changes. The roughly 30 minutes delay from 
admission to groin puncture in MRI-selected patients fits well with the reported data in real-
world patients (18) and underscore the importance to shorten in-hospital delays for MRI 
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patients. However, one has to bear in mind, that MRI patients were less severely affected and 
hence had less clear indications for MT like more distal occlusions.   
In our dataset, there was a non-significant trend for sICH occurring less frequently in patients 
selected with MRI. A lower percentage of MRI-selected patients received IVT before MT, a 
finding which was non-significant in our registry, although significant in another recent 
observational study (18). After adjusting for possible confounders including the lower rate of 
IVT in MRI-selected patients, this association was non-significant in our registry, but 
remained significant in the study by Kim et al. Overall, in parallel to IVT, MRI-selected MT 
patients appear to have an improved safety profile concerning sICH (23,24) compared to 
those selected with CT. This might be explained by MRI being more sensitive to detect subtle 
hemorrhagic changes within the ischemic lesion (25) or very severe white matter changes, and 
better estimation of the time elapsed in unknown or unwitnessed onsets, thereby allowing to 
withhold IVT in patients with higher risk to develop sICH.  
Our finding of improved functional outcome at three months for MRI-selected patients is in 
line with data from the mostly early time window HERMES collaboration (26)  and late time 
window DEFUSE-3 trials (27). Moreover, in SWIFT PRIME, MRI-selected patients had 
similar clinical and imaging outcomes as compared to CTP-selected patients, despite worse 
prognostic characteristics (21). Nevertheless, assignment bias might have influenced those 
findings, since the choice of imaging was not randomized in any of the aforementioned trials. 
It is noteworthy that real-world studies have found no relevant difference in functional 
outcome (18,21,22,27) between MRI- and CT-selected patient. Upcoming randomized 
controlled trials on this issue are on the horizon and will hopefully soon elucidate whether the 
type of imaging modality significantly influences outcome (NCT03745391). 
However, the main aim of this study was to sensitize stroke physicians that apparently the 
imaging modality influences their decisions regarding which patients to treat by MT. Whether 
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this results in an overall better, worse or equal outcome can only be judged by upcoming 
randomized controlled trials on this issue (NCT03745391). 
Given the large sample size and good quality data, we were able to include many pre- and 
post-interventional confounders in our model. Despite potential overadjustment, the 
association of MRI and reduced FR remained significant arguing for a real effect. Of course, 
this study has the limitations of a multicenter, single-arm, retrospective registry of a highly 
selected patient population. Most importantly, patient triage with MRI or CT was center-
specific; reasons to prefer one imaging modality in individual patients was not available, and 
no medical comparison group was available. Hence inference on the overall influence of the 
imaging modality on the subsequent indication rate for MT are not possible. We sought to 
address this issue by including the treating center as categorical factor in the multivariable 
analysis. A major limitation of our study is the absence of core-lab adjudicated recanalization 
grade, as well as pre- and post-interventional infarct volumes, among other factors. Moreover, 
the percentage of advanced perfusion studies and predictors shown to be associated with FR 
after EVT, including leukoaraiosis (7), were lacking. Additionally, no information was 
available on the rate of angiography, although all centers confirmed, that angiography was 
always intended and only skipped in cases of clinical problems (vomiting, agitation, …). 
Furthermore, more detailed workflow timepoints (admission to imaging time, imaging to 
puncture time, etc.) were not available, which hampers understanding differences in the 
workflow-related effects of each imaging modality. The date of the intervention was not 
known. However, the use of each imaging technique was consistent during the study period at 
each center and it is unclear how the expansion of indications for MT (e.g. more distal 
occlusions) might have influenced the occurrence of FR by each imaging modality. Finally – 
given the overall favorable prognostic profile of MRI patients - it remains possible that initial 
CT imaging might represent a surrogate marker of other residual confounding variables 
(frailty, off-hour treatment, poor general condition, and patients with pacemakers) and 
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selection bias might be present representing the true reason for increased rates of FR in those 
patients. Hence, our results need to be replicated by other groups and verified by upcoming 
randomized controlled trials on this issue (NCT03745391). 
Conclusion 
Patient selection for MT by CT was associated with an increased risk of FR compared to MRI 
selection. Further research is needed to clarify the role of the initial imaging modality on FR 
occurrence and to develop a reliable FR prediction algorithm which could be included into 
shared decision-making and elucidation of patient preferences. Efforts are still needed to 
shorten workflow delays in MRI patients. If confirmed in upcoming RCTs, cost-effectiveness 
analyses comparing CT with MR as the best initial imaging modality for MT seem warranted 
due to the ambivalence between MR-related costs and those associated with futile 
recanalization.  
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Tables 
 
 MRI, N=690 CT N=1321  Available 
of N=2011 
P 
Clinical items     
Age (years) 72 (60-80) 74 (62-82) 2011 0.003 
Sex (female) 351 (50.9%) 648 (49.1%) 2011 0.452 
NIHSS on admission 15 (9-19) 17 (12-21) 1983 <0.001 
Transfer from another hospital 171 (24.9%) 547 (41.4%) 2009 <0.001 
Stroke onset 
- witnessed  
- unwitnessed 
 
550 (79.7%) 
140 (20.3%) 
 
1080 (81.8%) 
241 (18.2%) 
2011 0.281 
Wake up Stroke 67 (11.3%) 92 (7.1%) 1894 0.003 
Pre stroke independence (mRS 0-2) 645 (95.1%) 1206 (91.9%) 1990 0.007 
Blood pressure systolic (mmHg) 153 (134 – 173) 148 (130 – 165) 1447 <0.001 
Blood pressure diastolic (mmHg) 81 (70 – 95) 80 (70 – 90) 1446 0.030 
Admission glucose (mmol/L) 6.6 (5.7-7.9) 6.8 (5.8-8.3) 1487 0.021 
Medication     
Antiplatelet 
- Mono 
- Dual 
 
187 (32.1%) 
8 (1.4%) 
 
367 (28.1%) 
18 (1.4%) 
1887 0.209 
Statin 133 (27.1%) 377 (31.0%) 1706 0.115 
Anticoagulation 
- VKA 
- DOAC 
 
43 (7.4%) 
18 (3.1%) 
 
175 (13.4%) 
55 (4.2%) 
1888 <0.001 
Etiology     
TOAST 
- Large artery 
- Cardioembolism 
- Other specific 
- Unknown 
 
83 (12.2%) 
269 (39.4%) 
44 (6.5%) 
286 (41.9%) 
 
194 (15.0%) 
644 (49.7%) 
97 (7.5%) 
360 (27.8%) 
1977 <0.001 
Risk factors     
Diabetes 117 (17.3%) 234 (17.8%) 1991 0.804 
Arterial Hypertension 443 (65.3%) 870 (66.4%) 1989 0.653 
Dyslipidemia 356 (52.8%) 636 (48.8%) 1977 0.097 
Smoking 198 (29.6%) 353 (28.3%) 1918 0.561 
Previous stroke 84 (12.3%) 184 (14.0%) 1996 0.333 
Imaging     
CT-/DWI-ASPECTS 8 (5-9) 9 (7-10) 1698 <0.001 
Tandem Occlusion 99 (14.4%) 207 (15.7%) 2009 0.472 
Location 
- Anterior 
- Posterior  
 
638 (92.5%) 
52 (7.5%) 
 
1159 (88.2%) 
155 (11.8%) 
2004 0.003 
Table 1 - Baseline characteristics of patients according to initial imaging modality.  
Results are presented as median (interquartile range) or absolute number (percentage). MRI: magnetic resonance imaging, 
CT: computer tomography, NIHSS: National Institute of Health Stroke Scale, mRS: modified Rankin Scale, VKA: vitamin K 
antagonist, DOAC: direct oral anticoagulant, TOAST: Trial of ORG 10172 in Acute Stroke Treatment, DWI: diffusion 
weighted imaging; ASPECTS: Acute Stroke Prognosis Early Computed Tomography Score 
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 Futile, N=571 Non-Futile N=918 Available 
of N=1489 
P 
Clinical items     
Age (years) 77 (67-84) 70 (58-79) 1489 <0.001 
Sex (female) 279/571 (48.9%) 438/918 (47.7%) 1489 0.670 
NIHSS on admission 18 (14-22) 14 (9-18) 1472 <0.001 
Transfer from another hospital 198/571 (34.7%) 299/917 (32.6%) 1488 0.429 
Known time of symptom onset 438/571 (76.7%) 768/918 (83.7%) 1489 0.001 
Wake up Stroke 52/539 (9.6%) 65/858 (7.6%) 1397 0.197 
Pre stroke independence 491/568 (86.4%) 885/910 (97.3%) 1478 <0.001 
Blood pressure systolic (mmHg) 152, SD 31 149, SD 27 1083 0.080 
Blood pressure diastolic (mmHg) 80, SD 19 82, SD 19 1082 0.097 
Admission glucose (mmol/L) 7.2 (6.1-8.8) 6.5 (5.7-7.6) 1117 <0.001 
Medication     
Antiplatelet 
- Mono 
- Dual 
 
166/541 (30.7%) 
8/541 (1.5%) 
 
232/862 (26.9%) 
10/862 (1.2%) 
1403 0.257 
Statin 153/485 (31.5%) 211/770 (27.4%) 1255 0.125 
Anticoagulation 
- VKA 
- NOAC 
 
64/544 (11.8%) 
28/544 (5.1%) 
 
84/861 (9.8%) 
34/861 (3.9%) 
1405 0.251 
Etiology     
TOAST 
- Large artery 
- Cardioembolism 
- Other specific 
- Unknown 
 
81/566 (14.3%) 
279/566 (49.3%) 
31/566 (5.5%) 
175/566 (30.9%) 
 
128/906 (14.1%) 
415/906 (45.8%) 
75/906 (8.3%) 
288/906 (31.8%) 
1472 0.188 
Risk factors     
Diabetes 120/564 (21.3%) 116/910 (12.7%) 1474 <0.001 
Arterial Hypertension 388/565 (68.7%) 572/910 (62.9%) 1475 0.025 
Dyslipidemia 273/561 (48.7%) 459/907 (50.6%) 1468 0.485 
Smoking 135/539 (25.0%) 277/880 (31.5%) 1419 0.010 
Previous stroke 87/563 (15.5%) 105/914 (11.5%) 1477 0.031 
Modality     
- MRI 
- CT 
152/571 (26.6%) 
419/571 (73.4%) 
380/918 (41.4%) 
538/918 (58.6%) 
1489 <0.001 
CT/MRI-ASPECTS 8 (6-9) 8 (7-10) 1247 0.001 
Tandem Occlusion 80/570 (14.0%) 135/917 (14.7%) 1487 0.762 
Location 
- Anterior 
- Posterior 
 
489/569 (85.9%) 
80/569 (14.1%) 
 
831/915 (90.8%) 
84/915 (9.2%) 
 
1484 
1484 
0.004 
Treatment     
IVT use 253/571 (44.3%) 467/918 (50.9%) 1489 0.014 
Time from onset of symptoms to IVT needle 
(min) 
131 (90-180) 125 (89-175) 419/720 0.470 
Time from onset of symptoms to admission 
(min) 
156 (75-265) 129 (70-239) 1317 0.007 
Procedure     
Additional intraarterial thrombolytics 45/537 (8.4%) 62/852 (7.3%) 1389 0.470 
Balloon guiding catheter  251/539 (46.6%) 425/857 (49.6%) 1396 0.272 
Number of thrombectomy passes 2 (1-2) 1 (1-2) 1029 <0.001 
Intracranial stenting 30/570 (5.3%) 20/916 (2.2%) 1486 0.002 
Extracranial stenting 64/571 (11.2%) 102/916 (11.1%) 1487 1.000 
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Time from onset of symptoms to groin 
puncture (min) 
230 (167–332) 222 (160-315) 1289 0.149 
Time from groin to recanalization 47 (31-78) 41 (28-65) 1463 <0.001 
General anesthesia 330/537 (61.5%) 458/857 (53.4%) 1394 0.004 
Interventional complication, any 67/570 (11.8%) 85/916 (9.3%) 1486  0.135 
TICI 3  301/571 (52.7%) 532/918 (58.0%) 1489 0.053 
 
Table 2 – Baseline and interventional characteristics of patients according to futility of 
recanalization.  
Results are presented as median (interquartile range), mean with standard deviation when indicated by SD, or absolute 
number (percentage). NIHSS: National Institute of Health Stroke Scale, VKA: vitamin K antagonist, DOAC: direct oral 
anticoagulant, TOAST: Trial of ORG 10172 in Acute Stroke Treatment, MRI: magnetic resonance imaging, CT: computer 
tomography, ASPECTS: Acute Stroke Prognosis Early Computed Tomography Score, TICI: thrombolysis in cerebral 
infarction classification of recanalization. 
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Outcome MRI CT  Available  P 
Futile recanalization (mRS 4-6) 152/532 (28.6%) 419/957 (43.8%) 1489/1676 <0.001 
Futile recanalization (mRS 5-6) 99/532 (18.6%) 294/957 (30.7%) 1489/1676 <0.001 
sICH ECASS II 30/688 (4.4%) 92/1309 (7.0%) 1997/2011 0.018 
mRS 0-3 424/665 (63.8%) 602/1130 (53.3%) 1795/2011 <0.001 
mRS 0-2  333/665 (50.1%) 446/1130 (39.5%) 1795/2011 <0.001 
mRS 0-1 218/665 (32.8%) 275/1130 (24.3%) 1795/2011 <0.001 
Mortality 136/665 (20.5%) 318/1130 (28.1%) 1795/2011 <0.001 
 
Table 3 – Outcome data comparing patients according to initial imaging modality on univariate χ2 
analysis.  
MRI: magnetic resonance imaging, CT: computed tomography, sICH ECASS II: symptomatic intracranial hemorrhage 
according to the European Co-operative Acute Stroke Study-II definition, mRS: modified Rankin Scale.  
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 MRI, N=690 CT N=1321  Difference 
in minutes 
Available 
of 
N=2011 
P 
Workflow metrics      
Time from onset of symptoms to 
admission (min) 
133 (73-274) 150 (75-245) 17 1754 0.657 
Time from onset of symptoms to IVT 
needle (min) 
150 (110-180) 113 (69-165) 37 552/964 <0.001 
Time from admission to groin 
puncture (min) 
100 (82-123) 76 (46-107) 24 1577 <0.001 
Time from onset of symptoms to 
groin puncture (min) 
240 (174 -359) 228 (165 – 314) 12 1727 0.001 
Time from groin to recanalization 48 (30-80) 45 (30-74) 3 1872 0.086 
Time from symptom onset to 
recanalization 
300 (225-409) 282 (215-375) 18 1619 0.005 
 
Table 4 – Workflow metrics of patients according to initial imaging modality.  
MRI: magnetic resonance imaging, CT: computer tomography. 
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Figure Legends 
 
Figure 1 – Registry flowchart. 
Figure 1 - TICI: thrombolysis in cerebral infarction recanalization score, mRS: modified Rankin Scale. 
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Figure 2 – Unadjusted and adjusted odds ratios of outcomes for initial imaging selection with 
CT as compared to MRI. 
Figure 2 - FR: futile recanalization; mRS: modified Rankin Scale; sICH: symptomatic intracranial hemorrhage. 
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Figure 3 – Subgroup analyses: adjusted odds ratios of the multiple regression analysis for 
association of CT versus MRI with the primary outcome of futile recanalization. 
Figure 3 - M1: Middle cerebral artery 1st segment, M2: Middle cerebral artery 2nd segment, ICA: internal carotid artery, 
ASPECTS: Alberta stroke program early CT score (1 point was added for MRI patients to control for the difference in DWI-
ASPECTS as compared to CT-ASPECTS).  
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